Selenium protects the immature rat heart against ischemia/reperfusion injury

. 2007 Jun ; 300 (1-2) : 259-67. [epub] 20061223

Jazyk angličtina Země Nizozemsko Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid17187170

The aim of the study was to find out whether administration of selenium (Se) will protect the immature heart against ischemia/reperfusion.The control pregnant rats were fed laboratory diet (0.237 mg Se/kg diet); experimental rats received 2 ppm Na(2)SeO(3) in the drinking water from the first day of pregnancy until day 10 post partum. The concentration of Se in the serum and heart tissue was determined by activation analysis, the serum concentration of NO by chemiluminescence, cardiac concentration of lipofuscin-like pigment by fluorescence analysis. The 10 day-old hearts were perfused (Langendorff); recovery of developed force (DF) was measured after 40 min of global ischemia. In acute experiments, 10 day-old hearts were perfused with selenium (75 nmol/l) before or after global ischemia. Sensitivity to isoproterenol (ISO, pD(50)) was assessed as a response of DF to increasing cumulative dose.Se supplementation elevated serum concentration of Se by 16%. Se increased ischemic tolerance (recovery of DF, 32.28 +/- 2.37 vs. 41.82 +/- 2.91%, P < 0.05). Similar results were obtained after acute administration of Se during post-ischemic reperfusion (32.28 +/- 2.37 vs. 49.73 +/- 4.40%, P < 0.01). The pre-ischemic treatment, however, attenuated the recovery (23.08 +/- 3.04 vs. 32.28 +/- 2.37%, P < 0.05). Moreover, Se supplementation increased the sensitivity to the inotropic effect of ISO, decreased cardiac concentration of lipofuscin-like pigment and serum concentration of NO. Our results suggest that Se protects the immature heart against ischemia/reperfusion injury. It seems therefore, that ROS may affect the function of the neonatal heart, similarly as in adults.

Zobrazit více v PubMed

J Mol Cell Cardiol. 1995 Oct;27(10):2303-14 PubMed

Antioxid Redox Signal. 2005 Sep-Oct;7(9-10):1388-97 PubMed

Pediatr Res. 2002 Oct;52(4):561-7 PubMed

J Mol Cell Cardiol. 1998 Jul;30(7):1391-9 PubMed

Basic Res Cardiol. 1998 Jun;93(3):156-62 PubMed

Circ Res. 1999 Feb 19;84(3):253-6 PubMed

Free Radic Biol Med. 2003 Oct 1;35(7):742-51 PubMed

J Mol Cell Cardiol. 1998 Apr;30(4):857-65 PubMed

Am J Physiol. 1993 May;264(5 Pt 2):H1478-84 PubMed

J Agric Food Chem. 2005 Jan 26;53(2):490-4 PubMed

Zhonghua Yi Xue Za Zhi. 1999 Nov;79(11):852-6 PubMed

Experientia. 1978 Feb 15;34(2):222-3 PubMed

Circulation. 1986 Nov;74(5):1124-36 PubMed

J Clin Invest. 1976 May;57(5):1302-7 PubMed

Physiol Rev. 1999 Jul;79(3):635-59 PubMed

Ann Intern Med. 1960 Aug;53:247-58 PubMed

Redox Rep. 2004;9(6):317-20 PubMed

Mol Cell Biochem. 2005 Feb;270(1-2):131-8 PubMed

Cardiovasc Res. 2000 Aug 18;47(3):446-56 PubMed

Biomed Environ Sci. 1997 Sep;10(2-3):260-70 PubMed

Methods Mol Biol. 1998;100:111-27 PubMed

J Anim Sci. 1999 Jan;77(1):223-9 PubMed

Comp Biochem Physiol A Mol Integr Physiol. 1999 Jul;123(3):221-34 PubMed

Cardioscience. 1992 Sep;3(3):155-60 PubMed

Biochem J. 2000 Oct 15;351 Pt 2:485-93 PubMed

Basic Res Cardiol. 1987 Jan-Feb;82(1):36-50 PubMed

Arch Toxicol. 1982 Mar;49(3-4):247-52 PubMed

Fed Proc. 1966 Jul-Aug;25(4):1243-6 PubMed

Cardiovasc Res. 1999 Mar;41(3):514-23 PubMed

J Nutr. 2003 May;133(5 Suppl 1):1517S-20S PubMed

Am J Physiol Heart Circ Physiol. 2003 Feb;284(2):H442-8 PubMed

Am J Physiol. 1998 Jan;274(1):C245-52 PubMed

Int J Biochem Cell Biol. 1999 Jun;31(6):671-81 PubMed

J Mol Cell Cardiol. 1993 Jun;25(6):733-40 PubMed

Hypertension. 1986 Dec;8(12):1096-104 PubMed

J Dairy Sci. 1981 May;64(5):814-21 PubMed

Regul Toxicol Pharmacol. 1999 Apr;29(2 Pt 1):142-50 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace